The aldosterone to renin ratio (ARR) is the guideline-recommended screening test for primary aldosteronism. However, there are limited data in regard to the diagnostic performance of the ARR. We searched the MEDLINE, Embase, and Cochrane databases until February 2020. Observational studies assessing ARR diagnostic performance as a screening test for primary aldosteronism were selected. To limit verification bias, only studies where dynamic confirmatory testing was implemented as a reference standard regardless of the ARR result were included. Study-level data were extracted and risk of bias and applicability were assessed using the QUADAS-2 tool. ARR performance varied widely based on patient population and diagnostic criteria, especially with respect to sensitivity. Therefore, no single ARR threshold for interpretation could be recommended. Limitations in accuracy and reliability of the ARR must be recognized in order to appropriately inform clinical decision-making.
Authors: Annie Hung, Sumaiya Ahmed, Ankur Gupta, Alexandra Davis, Gregory A Kline, Alexander A Leung, Marcel Ruzicka, Swapnil Hiremath, Gregory L Hundemer
Keywords: aldosterone renin ratio, ARR, screening
DOI Number: 10.1210/clinem/dgab348 Publication Year: 2021
To search for other research papers by topic, keyword, author, or year, please go to our Publications page.